Oxytetracycline hydrochloride (OTIMM) is an aquaculture premix containing oxytetracycline hydrochloride and is available through Pharmgate. OTIMM is available for purchase through many local farm & ranch stores or veterinarian supply outlets. The primary goal of field studies conducted under INAD #9033 is to evaluate the efficacy of OTIMM for controlling mortality in a variety of freshwater and marine finfish species for bacterial diseases. Immersion therapy is often the only option when treating young fish not yet accustomed to feeding on man-made fish diets. Reluctance or refusal of young fish to consume such feed excludes medicated feed treatment as a therapy option. The treatment regimen is a 1-h static-bath or flow-through treatment at a dose of 20 mg OTC/L, and fish may be treated up to 4 consecutive days. The Investigational withdrawal period is 21 days for fish treated a single treatment and 60 days for multiple treatments. To participate in the INAD Program for OTIMM visit the data collecting site.
Please read the Study Protocol prior to any treatments. It contains the protocol, MSDS, and a copy of the forms to be used as a guide for collecting data that will be entered into the online INAD database. The FDA authorization letter(s) for this INAD is currently only available by emailing Bonnie Johnson. Microcrystalline Cellulose
Pharmgate (often available from your local farm & ranch store, veterinary supply outlet, etc.) 14040 Industrial Road Omaha , NE 68144 United States
Investigator must collect mortality data throughout the 5 day pre-treatment, treatment, and 10 day post-treatment periods. Investigator should also report general fish behavior and any adverse effects relating to treatment.
Tripterine Working with others to conserve, protect and enhance fish, wildlife, plants and their habitats for the continuing benefit of the American people.